Craig K. Svensson

2.9k total citations
74 papers, 2.4k citations indexed

About

Craig K. Svensson is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Craig K. Svensson has authored 74 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 22 papers in Molecular Biology and 21 papers in Pharmacology. Recurrent topics in Craig K. Svensson's work include Pharmacogenetics and Drug Metabolism (19 papers), Drug-Induced Adverse Reactions (11 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Craig K. Svensson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (19 papers), Drug-Induced Adverse Reactions (11 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Craig K. Svensson collaborates with scholars based in United States, Sweden and Switzerland. Craig K. Svensson's co-authors include Robert K. Drobitch, Patrick M. Woster, Sanjoy Roychowdhury, David Lalka, Anthony A. Gaspari, Edward W. Cowen, Timothy P. Reilly, James G. Baxter, Michael J. Rybak and David J. Edwards and has published in prestigious journals such as JAMA, Nucleic Acids Research and Pharmacological Reviews.

In The Last Decade

Craig K. Svensson

74 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig K. Svensson United States 25 755 478 383 286 260 74 2.4k
Bernd Rosenkranz South Africa 32 545 0.7× 540 1.1× 586 1.5× 229 0.8× 259 1.0× 115 3.3k
Peter A. Todd France 28 1.0k 1.4× 605 1.3× 249 0.7× 192 0.7× 207 0.8× 40 3.7k
Anita Conforti Italy 32 585 0.8× 221 0.5× 321 0.8× 204 0.7× 252 1.0× 105 2.4k
Françoise Bressolle France 32 667 0.9× 653 1.4× 254 0.7× 138 0.5× 263 1.0× 182 3.6k
Walid M. Awni United States 30 454 0.6× 489 1.0× 531 1.4× 323 1.1× 602 2.3× 139 3.0k
Thomas M Annesley United States 25 461 0.6× 987 2.1× 246 0.6× 193 0.7× 388 1.5× 99 3.7k
Michael Mayersohn United States 34 579 0.8× 837 1.8× 692 1.8× 204 0.7× 314 1.2× 160 3.8k
Robert B. Parker United States 27 453 0.6× 779 1.6× 271 0.7× 181 0.6× 127 0.5× 100 2.6k
Mario L. Rocci United States 24 360 0.5× 326 0.7× 466 1.2× 178 0.6× 322 1.2× 73 2.1k
Peter H. Vlasses United States 28 359 0.5× 486 1.0× 261 0.7× 205 0.7× 307 1.2× 176 2.9k

Countries citing papers authored by Craig K. Svensson

Since Specialization
Citations

This map shows the geographic impact of Craig K. Svensson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig K. Svensson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig K. Svensson more than expected).

Fields of papers citing papers by Craig K. Svensson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig K. Svensson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig K. Svensson. The network helps show where Craig K. Svensson may publish in the future.

Co-authorship network of co-authors of Craig K. Svensson

This figure shows the co-authorship network connecting the top 25 collaborators of Craig K. Svensson. A scholar is included among the top collaborators of Craig K. Svensson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig K. Svensson. Craig K. Svensson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svensson, Craig K.. (2022). Opioid-induced hyperalgesia: is it a clinically relevant phenomenon?. International Journal of Pharmacy Practice. 30(5). 479–483. 4 indexed citations
2.
Svensson, Craig K.. (2022). Attenuation of Response to Repeated Drug Administration: A Proposal for Differentiating Tachyphylaxis and Tolerance. Journal of Pharmacology and Experimental Therapeutics. 381(1). 22–32. 5 indexed citations
3.
Svensson, Craig K.. (2015). Should a Pharmacy Dean be a Pharmacist?. American Journal of Pharmaceutical Education. 79(3). 32–32. 4 indexed citations
4.
Svensson, Craig K., Diego Iglesias‐Gato, See‐Tong Pang, et al.. (2013). REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer. Nucleic Acids Research. 42(2). 999–1015. 116 indexed citations
5.
Kehrer, James P. & Craig K. Svensson. (2012). Advancing Pharmacist Scholarship and Research Within Academic Pharmacy. American Journal of Pharmaceutical Education. 76(10). 187–187. 19 indexed citations
6.
Roychowdhury, Sanjoy, et al.. (2007). Detection of Haptenated Proteins in Organotypic Human Skin Explant Cultures Exposed to Dapsone. Drug Metabolism and Disposition. 35(9). 1463–1465. 8 indexed citations
7.
Roychowdhury, Sanjoy, Farah Khan, Thomas E. Prisinzano, et al.. (2006). Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: I. Expression and Role of Cytochromes P450. Journal of Pharmacology and Experimental Therapeutics. 319(1). 488–496. 33 indexed citations
8.
O’Neil, William M., Rodger D. MacArthur, Mark A. Doll, et al.. (2002). Acetylator Phenotype and Genotype in HIV‐Infected Patients with and without Sulfonamide Hypersensitivity. The Journal of Clinical Pharmacology. 42(6). 613–619. 26 indexed citations
9.
Reilly, Timothy P., Lawrence H. Lash, Mark A. Doll, et al.. (2000). A Role for Bioactivation and Covalent Binding within Epidermal Keratinocytes in Sulfonamide-Induced Cutaneous Drug Reactions. Journal of Investigative Dermatology. 114(6). 1164–1173. 132 indexed citations
10.
O’Neil, William M., Robert K. Drobitch, Rodger D. MacArthur, et al.. (2000). Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype. Pharmacogenetics. 10(2). 171–182. 39 indexed citations
11.
Drobitch, Robert K., et al.. (1998). Effect of Streptolysin-O on Rat HEPATIC Acetyl Coenzyme- A: ArylamineN-Acetyltransferase and Cytochrome P-450 2B1/2 ActivitiesEx Vivo. Immunopharmacology and Immunotoxicology. 20(1). 159–171. 1 indexed citations
12.
Tisdale, James E., Maria I. Rudis, I. Desmond Padhi, et al.. (1996). Disposition of Procainamide in Patients with Chronic Congestive Heart Failure Receiving Medical Therapy. The Journal of Clinical Pharmacology. 36(1). 35–41. 12 indexed citations
13.
Preuss, Charles & Craig K. Svensson. (1996). Arylacetamide deacetylase activity towards monoacetyldapsone. Biochemical Pharmacology. 51(12). 1661–1668. 16 indexed citations
14.
Svensson, Craig K., et al.. (1991). Disposition of Sulfamethazine and N-Acetylsulfamethazine in the Rat. Pharmaceutical Research. 8(8). 1069–1070. 4 indexed citations
15.
Svensson, Craig K., et al.. (1989). Effect of the Immunomodulator Tilorone on the in Vivo Acetylation of Procainamide in the Rat. Pharmaceutical Research. 6(6). 477–480. 16 indexed citations
16.
Svensson, Craig K.. (1988). Is blood sampling for determination of antipyrine pharmacokinetics in healthy volunteers ethically justified?. Clinical Pharmacology & Therapeutics. 44(4). 365–368. 13 indexed citations
17.
Svensson, Craig K., et al.. (1988). Monthly variations in the pharmacokinetics of antipyrine in the rat: circannual rhythm or random variation?. PubMed. 59(1). 53–60. 1 indexed citations
18.
Svensson, Craig K., et al.. (1987). Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat.. Pharmaceutical Research. 4(3). 251–254. 5 indexed citations
19.
Svensson, Craig K.. (1987). Clinical pharmacokinetics of nicotine. Journal of Ethnopharmacology. 20(3). 298–298. 3 indexed citations
20.
Svensson, Craig K., et al.. (1986). Free Drug Concentration Monitoring in Clinical Practice. Clinical Pharmacokinetics. 11(6). 450–469. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernd Rosenkranz Breakdown of academic impact, for papers by Peter A. Todd Breakdown of academic impact, for papers by Anita Conforti Breakdown of academic impact, for papers by Françoise Bressolle Breakdown of academic impact, for papers by Walid M. Awni Breakdown of academic impact, for papers by Thomas M Annesley Breakdown of academic impact, for papers by Michael Mayersohn Breakdown of academic impact, for papers by Robert B. Parker Breakdown of academic impact, for papers by Mario L. Rocci Breakdown of academic impact, for papers by Peter H. Vlasses
Rankless by CCL
2026